Fingerprint
Dive into the research topics of 'Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
emBRAce, kConFab Investigators, Australian ovarian cancer study group
- Universidade de São Paulo
- University of Cambridge
- Mayo Clinic Rochester, MN
- University of Kansas
- Peter Maccallum Cancer Centre
- University of Southern California
- University of Sydney
- National Institutes of Health
- University of Edinburgh
- University of Dundee
- Cedars-Sinai Medical Center
- Lund University
- Royal Marsden NHS Foundation Trust
- Centro Nacional de Investigaciones Oncológicas
- University of Toronto
- University Health Network
- Institute Catala Oncologia
- Stanford University
- IRCCS Istituto Oncologico Veneto - Padova
- The Gertner Institute
- Cancer Genetics Center
- Danish Cancer Society
- University of Copenhagen
- City of Hope National Med Center
- University of California at San Francisco
- Fox Chase Cancer Center
- Roswell Park Cancer Institute
- Ohio State University
- KU Leuven
- Cambridge University Hospitals NHS Foundation Trust
- Cambridge Experimental Cancer Medicine Centre
- Queensland Institute of Medical Research
Research output: Contribution to journal › Article › peer-review
138
Scopus
citations